VE-cadherin Regulates Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Sensitivity to Apoptosis

ISSN： 1875-2292

Source： Cancer Microenvironment, Vol.3, Iss.1, 2010-12, pp. : 67-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib-based therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report and literature review

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2051-2054

Spandidos Publications

Access to resources Recommend Favorite

Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph+ALL04

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 682-689

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion

By Czyz Anna

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1123-1126

Humana Press, Inc

Access to resources Recommend Favorite

Transient pancytopenia preceding adult acute lymphoblastic leukemia with chromosomal abnormalities including the Philadelphia chromosome: A case report and review of the literature

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3789-3792

Spandidos Publications

Access to resources Recommend Favorite

PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells

International Journal of Oncology, Vol. 42, Iss. 2, 2013-01 ,pp. : 419-428

Spandidos Publications

Access to resources Recommend Favorite